Patient-Reported Outcomes of Benralizumab in Real-World Use in Severe Eosinophilic Asthma Patients in Taiwan (BEAT)

Real World Study With Benralizumab in Severe Asthma in Switzerland

NCT03907137 ·Status: COMPLETED

Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI

NCT03733535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics

NCT03953300 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

NCT01947946 ·Status: TERMINATED ·Phase: PHASE3

Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.

NCT03833141 ·Status: COMPLETED

STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma

NCT06465485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Taiwan Severe Asthma Biologic Registry

NCT06456450 ·Status: RECRUITING

A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation

NCT02869438 ·Status: COMPLETED ·Phase: PHASE3

Study in Portuguese Hospitals to Describe Patient Characteristics, Treatment Patterns and Outcomes

NCT07159295 ·Status: COMPLETED

A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.

NCT03170271 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

NCT01928771 ·Status: COMPLETED ·Phase: PHASE3

Characterization and Clinical Outcomes of Severe Asthma Patients in Israel Treated With Benralizumab (SAIL-B)

NCT07218172 ·Status: COMPLETED

A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

NCT07214753 ·Status: RECRUITING

Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics

NCT02821416 ·Status: COMPLETED ·Phase: PHASE3

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

NCT04305405 ·Status: COMPLETED ·Phase: PHASE3

Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations

NCT05417906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Observational Retrospective Study on Clinical Outcomes of Patients Receiving Benralizumab in Spain.

NCT04648839 ·Status: COMPLETED

Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma

NCT03557307 ·Status: COMPLETED ·Phase: PHASE3

A Non-interventional, Prospective Study With Benralizumab

NCT06422078 ·Status: RECRUITING

A Phase 2a Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Adults With Asthma

NCT00783289 ·Status: COMPLETED ·Phase: PHASE2

Benralizumab in the Treatment of Patients With Severe Asthma With ABPA

NCT04108962 ·Status: WITHDRAWN ·Phase: PHASE4

Benralizumab Exacerbation Study

NCT04102800 ·Status: COMPLETED ·Phase: PHASE4

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

NCT00784953 ·Status: COMPLETED

BenRalizumab Effect on Airway Remodeling in Severe asTHma

NCT06288516 ·Status: RECRUITING ·Phase: PHASE4

A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563).

NCT00768079 ·Status: COMPLETED ·Phase: PHASE2